Blueberry Pediatrics provides round-the-clock pediatric telehealth paired with an at-home diagnostic kit, so a parent worried about a child at midnight can reach a clinician and supply real physical data rather than describing symptoms over video. The kit typically includes tools such as a pulse oximeter and otoscope, which is what separates the service from generic telemedicine: the clinician can assess oxygen saturation or look at an ear rather than defaulting to send them to urgent care.

That capability changes the economics for everyone involved. Families avoid emergency room visits for conditions manageable at home, and payers, including Medicaid plans, avoid the far larger cost of those visits, which is why the model can be sold as covered care rather than a subscription. Backed since 2020 and funded through a 9 million dollar Series A, Blueberry is a deep-domain investment where clinical licensure, device logistics, and payer contracting are the difficult parts. Membership economics tied to avoided emergency visits also make the value proposition legible to the payers writing the cheques.